Novartis Pharma AG And Chugai Pharmaceutical Co., Ltd. (Japan) To Ship Agent For Postmenopausal Breast Cancer

May 11, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Tokyo, May 11, 2006 (JCN) - On May 10, Novartis Pharma and Chugai Pharmaceutical jointly announced that they will release Femara Tablet 2.5mg (letrozole), an agent for the treatment of postmenopausal breast cancer, on May 11.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Asia